While research and development of gene therapy has experienced its share of hurdles in recent years, it has also begun demonstrating its potential.
As a result of the technical sophistication and aggressive development by commercial and academic entities, the continued financial support evincing
its real promise, and the unabated clinical need of numerous patient populations, gene therapy is indeed headed toward market approval and
introduction by the end of this decade.
This report will be a detailed assessment of the status of development in gene therapy and the outlook for its commercial introduction. The
report will detail the techniques, technologies, and target clinical applications being pursued, with detailed data and insights on specific products
and the numerous competitors vying to reach the market. The report will provide a well-grounded assessment of the remaining clinical and
commercial hurdles, providing a ten-year outlook for genetically based therapies. The report's analysis will reveal windows of opportunity for current
or hopeful competitors.
View Cart
